Hematologist-Oncologist: Patricia Robinson, MD | Loyola Medicine

Patricia Robinson, MD

Patricia Robinson, MD


Associate Professor
Assistant Dean - Diversity, Equity and Inclusion, SSOM

Languages Spoken

Patient Ratings
4.9 / 5 (84 Ratings)

Clinical Expertise

  • Breast Cancer
  • Chemoprevention Of Breast Cancer

About Dr. Robinson


Medical Education

Medical School
Michigan State University College of Human Medicine
Loyola University Medical Center - Internal Medicine: General
  • Fox Chase Cancer Center/Temple University Hospital - Hematology/Oncology

Board Certification

American Board of Internal Medicine Subspecialty Medical Oncology


  • American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce Winkfield, K. M.; Flowers, C. R.; Patel, J. D.; Rodriguez, G.; Robinson, P.; Agarwal, A.; Pierce, L.; Brawley, O. W.; Mitchell, E. P.; Head-Smith, K. T.; Wollins, D. S.; Hayes, D. F., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Patient Simulator for Teaching Heart and Lung Assessment Skills to Advanced Practice Nursing Students Tiffen, Jennifer; Corbridge, Susan; Shen, Bernadette, Cuasay; Robinson, Patrick, Clinical Simulation in Nursing
  • Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Grudzien, P.; Lo, S.; Albain, K. S.; Robinson, P.; Rajan, P.; Strack, P. R.; Golde, T. E.; Miele, L.; Foreman, K. E., Anticancer Research
View All ResearchShow Less
  • Residual disease after neoadjuvant chemotherapy for breast cancer Morris, G. J.; Robinson, P. A.; Lo, S.; Samuel, T. A.; Sheikh, A. A.; Jordan, W. E., 3rd; Thomas, L. C.; Kiel, K.; Peters, C. A., Seminars in oncology
  • Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings Lo, S. S.; Pritchard, K. I.; Robinson, P.; Albain, K. S., Cancer treatment and research
  • Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. Camacho, P. M.; Dayal, A. S.; Diaz, J. L.; Nabhan, F. A.; Agarwal, M.; Norton, J. G.; Robinson, P. A.; Albain, K. S., Journal of Clinical Oncology
  • Mammalian septins nomenclature Macara, I. G.; Baldarelli, R.; Field, C. M.; Glotzer, M.; Hayashi, Y.; Hsu, S. C.; Kennedy, M. B.; Kinoshita, M.; Longtine, M.; Low, C.; Maltais, L. J.; McKenzie, L.; Mitchison, T. J.; Nishikawa, T.; Noda, M.; Petty, E. M.; Peifer, M.; Pringle, J. R.; Robinson, P. J.; Roth, D.; Russell, S. E.; Stuhlmann, H.; Tanaka, M.; Tanaka, T.; Trimble, W. S.; Ware, J.; Zeleznik-Le, N. J.; Zieger, B., Molecular biology of the cell